Functional Diffusion Map Algorithms for Bone Lesion Monitoring
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating cancer lack effective tools to accurately assess the response of bone tumors to treatment, leading to challenges in evaluating treatment effectiveness and drug development, particularly due to the complex nature of bone lesions and the limitations of conventional imaging technologies.
Innovation Solution
The use of functional diffusion map algorithms for monitoring changes in water diffusion within tissue regions over time, allowing for the assessment of treatment effectiveness through MRI, which can detect increases or decreases in water diffusion indicative of cellular destruction or swelling, thereby providing a more accurate evaluation of treatment response.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional imaging technologies (CT, MRI, bone scans) are used to assess treatment response in bone lesions, then anatomical information can be obtained, but the complex nature of bone lesions and constant bone remodeling limit the accuracy and reliability of treatment response assessment
Solution Approach 1:
The patent applies parameter changes by transitioning from conventional anatomical imaging parameters to diffusion-weighted imaging parameters. The diffusion coefficient (ADC) provides a new physical parameter that reflects cellular density and membrane integrity rather than just anatomical structure. This allows detection of treatment response at the cellular level, overcoming the limitations of bone remodeling affecting anatomical measurements.
Solution Approach 2:
The patent replaces conventional mechanical/anatomical imaging systems with a diffusion-based imaging approach. Instead of relying on structural changes visible on CT or MRI, the system uses diffusion-weighted MRI to detect changes in water molecule movement, which directly reflect cellular integrity and treatment effect in bone lesions.
2Measurement precision
If pathologic complete response is used as a surrogate endpoint for clinical benefit in breast cancer treatment evaluation, then treatment effectiveness can be assessed, but the evaluation timepoint is delayed by 3-6 months
Solution Approach 1:
The patent applies preliminary action by detecting treatment response early in the treatment course using diffusion-weighted imaging, before pathologic complete response can be confirmed. The diffusion coefficient changes occur at the cellular level during treatment, allowing prediction of eventual pathologic response without waiting 3-6 months. This enables earlier identification of responders and non-responders.
Solution Approach 2:
The patent introduces the diffusion coefficient (ADC) as an intermediary parameter that bridges the gap between treatment administration and final pathologic outcome. The ADC value serves as an early biomarker that reflects cellular changes induced by treatment, providing a surrogate endpoint that predicts eventual pathologic complete response without requiring waiting for the full 3-6 month evaluation period.
3Reliability
If chemotherapy is administered to treat cancer, then cancer cells can be targeted and destroyed, but toxicity to other tissues in the body occurs
Solution Approach 1:
The patent applies feedback by using diffusion-weighted imaging to continuously monitor treatment response in real-time. The diffusion coefficient provides feedback on whether chemotherapy is effectively destroying cancer cells. This feedback enables dynamic adjustment of treatment dosage and duration, allowing optimization of cancer cell kill while minimizing overall toxicity by stopping or reducing treatment once sufficient response is achieved.
Solution Approach 2:
The patent applies partial action by using diffusion-weighted imaging to identify and treat only the specific regions where cancer cells are present and most active. Instead of treating the entire body systemically, the approach can be tailored to target specific tumor regions, potentially reducing the total dose required and thereby minimizing toxicity to normal tissues while maintaining effective cancer treatment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables early and accurate monitoring of treatment response in bone lesions and other tissue regions, improving the assessment of treatment effectiveness and reducing systemic toxicity and healthcare costs by allowing for individualized treatment strategies.
Implementation Method 1
The present invention provides systems and methods for monitoring tissue regions. In particular, the present invention provides systems and methods for detecting changes in tissue regions over a period of time. In some embodiments, the systems and methods employ functional diffusion map algorithms for imaging changes in tissue regions over time and/or in response to therapeutic interventions.
Data Source
AI summary
The present invention provides systems and methods for monitoring tissue regions. In particular, the present invention provides systems and methods for detecting changes in tissue regions over a period of time. In some embodiments, the systems and methods of the present invention are used to evaluate the effectiveness of a particular treatment of a tissue region. In some embodiments, the systems and methods employ functional diffusion map algorithms for imaging changes in tissue regions over time and/or in response to therapeutic interventions.